Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MPN Advances Day 2019 | The effect of vorinostat on methylation age in MPN patients

Mary Frances McMullin, MD, Queen’s University Belfast, Belfast, UK, discusses the effect of vorinostat on methylation age in myeloproliferative neoplasm (MPN) cell lines, and in patients with polycythemia vera (PV) and essential thrombocythemia (ET). The full paper can be read at https://www.ncbi.nlm.nih.gov/pubmed/31563618. This interview took place at the MPN Advances Day 2019 in London, UK.